Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
In vivo agonistic GITR antibody treatment
Ask a
question
Favorite
At the end of 4-NQO or propylene glycol treatments, mice were injected intraperitoneally with 10 µg of the agonistic GITR antibody DTA-1 (BioXCell, West Hanover, NH, #BE0063) or rat IgG2b isotype control. Mice were treated every Tuesday and Friday for 2.5 weeks and were harvested the day after the last injection.
Copyright and License information: ©2022 The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
